press center press release

PAREXEL International Corporation (PRXL) Chairman and CEO to Ring the NASDAQ Stock Market Opening Bell

Published

ADVISORY, June 5, 2007 (PRIME NEWSWIRE) --

What: Josef von Rickenbach, Chairman and CEO of PAREXEL International Corporation (PRXL), will preside over the opening bell in honor of the Company's 25th anniversary of providing clinical, technology and consulting services to the pharmaceutical, biotechnology and medical device industries. Where: NASDAQ MarketSite - 4 Times Square - 43rd and Broadway - Broadcast Studio When: Wednesday, June 6, 2007 at 9:30 a.m. ET Contacts: Karen Wills, Vice President Corporate Marketing PAREXEL International Tel: +781-434-5301 Email: karen.wills@PAREXEL.com NASDAQ MarketSite: Jolene Libretto; 646.441.5220; mobile - 347.219.9539 Jolene.Libretto@NASDAQ.com

Feed Information:

The opening bell is available from 9:20 a.m. to 9:35 a.m. on uplink IA6 C band / transponder 24, downlink frequency 4180 horizontal. The feed can also be found on Waterfront fiber 1623. If you have any questions, please contact Jolene Libretto at (646) 441-5220.

Radio Feed:

An audio transmission of the opening bell is also available from 9:20 a.m. to 9:35 a.m. on uplink IA6 C band / transponder 24, downlink frequency 4180 horizontal. The feed can be found on Waterfront fiber 1623 as well.

Webcast:

A live webcast of the NASDAQ Closing Bell will be available at: http://www.nasdaq.com/reference/marketsite_about.stm.

Photos:

To obtain a hi-resolution photograph of the Market Open, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market open of your choice.

About PAREXEL International Corporation (PRXL):

PAREXEL International Corporation is a leading global bio/pharmaceutical services organization, providing a broad range of knowledge-based contract research, medical communications and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 55 locations throughout 43 countries around the world, and has over 6,315 employees. For more information about PAREXEL International visit www.PAREXEL.com.

In This Story

NDAQ

Nasdaq Press Center

Read the latest press releases, request a press kit, and get in touch with our press team.

learn more